![2dia-circ](https://saniushealth.com/wp-content/uploads/2023/10/2dia-circ.png)
SICKLE CELL DISEASE
Real-World Outcomes and Digitally Monitored Quality of Life in Crizanlizumab-Treated Patients With Sickle Cell Disease
European Haematology Association (2023)
Areas of interest /
Outcomes research & novel therapeutic impacts
Biomarkers /
EQ-5D-5L, Side Effects, Disease Symptoms
Published in /
HemaSphere, European Haematology Association